CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113430072
- Phone
- (857) 209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-09 | GANZI VICTOR F Director | Conversion | +18,741 | $11.57 | $217K | 405,405 |
| 2021-02-09 | GANZI VICTOR F Director | Conversion | +50,122 | $11.57 | $580K | 455,527 |
| 2021-02-09 | GANZI VICTOR F Director | Option exercise | +367,590 | $6.43 | $2.4M | 823,117 |
| 2021-02-09 | GANZI VICTOR F Director | Sale | −246,720 | $16.00 | $3.9M | 576,397 |
| 2021-02-09 | GANZI VICTOR F Director | Conversion · Convertible Promissory Note | −0 | 0 | ||
| 2021-02-09 | GANZI VICTOR F Director | Conversion · Convertible Promissory Note | −0 | 0 | ||
| 2021-02-09 | GANZI VICTOR F Director | Option exercise · Warrant to Purchase Common Stock | −367,590 | 0 | ||
| 2021-02-04 | Neylan John F. See Remarks | Grant or award · Stock Option (Right to Buy) | +70,012 | 70,012 | ||
| 2021-02-04 | Goldberg Itzhak See Remarks | Grant or award · Stock Option (Right to Buy) | +70,012 | 70,012 | ||
| 2021-02-04 | Venkatesan Jay See Remarks | Grant or award · Stock Option (Right to Buy) | +178,920 | 178,920 | ||
| 2021-02-04 | Rhodes Jennifer J See Remarks | Grant or award · Stock Option (Right to Buy) | +70,012 | 70,012 |
Page 9 of 9 · 171 trades